PM Cuts Full-Year EPS Guidance Despite Strong Q2 Results
PM sits 32% above its 52-week low of $142.11.
Summary
Philip Morris International reported robust Q2 financial performance but reduced its full-year adjusted EPS forecast, indicating a more conservative outlook for the remainder of the year.
Key Events · Earnings and Guidance · PM
-
Full-Year EPS Guidance Cut
Philip Morris International significantly lowered its full-year 2026 adjusted diluted EPS forecast to a range of $8.26-$8.41, down from the previous range of $8.31-$8.46. This follows a prior guidance update on June 2, 2026.
-
Strong Q2 Financial Performance
The company reported Q2 2026 net revenues of $11.2 billion, an increase of 10.4% (7.6% organically), and adjusted diluted EPS of $2.20, up 15.2% (13.6% excluding currency).
-
Smoke-Free Business Momentum
Smoke-free products continued to drive growth, with shipments increasing by 7.5% and accounting for approximately 42% of total net revenues. IQOS, ZYN, and VEEV showed strong performance and market expansion.
-
Non-Cash Impairment Charge
A non-cash impairment charge of $511 million ($0.33 per diluted EPS) was recorded in Q2 2026 related to the equity investment in its Canadian affiliate, RBH.
Analysis · PM · Manufacturing
Philip Morris International delivered strong second-quarter results with double-digit revenue and adjusted EPS growth, primarily driven by its smoke-free product portfolio. However, the company significantly lowered its full-year adjusted EPS guidance, which is a material negative signal for future profitability. This guidance cut, occurring while the stock is trading near its 52-week high, could lead to investor concern regarding the company's outlook, despite the positive Q2 performance and continued growth in smoke-free categories. A non-cash impairment charge also impacted reported earnings.
At the time of this filing, PM was trading at $187.45 on NYSE in the Manufacturing sector, with a market capitalization of approximately $293.1B. The 52-week trading range was $142.11 to $194.90. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.